High demand leads to shortage of key drug to treat Black Fungus
The Hindu
‘Sudden rise in demand for Liposomal Amphotericin B, less stocks’
An exponential growth in demand for Liposomal Amphotericin B amid more people contracting Mucormycosis has resulted in an acute shortage of the key, expensive drug used in the treatment of the rare fungal infection. It was business as usual until even a fortnight ago for those dealing in the drug. “Suddenly, the quantities [sought] have doubled and the companies producing the drug say there is no stock,” said managing director of Medihauxe Pharma P. Girish Bhat. “Since yesterday, more than 150 patients with Mucormycosis or Black Fungus as it is also known are in touch with us in Hyderabad alone for the drug,” he said on Thursday, even while pointing that the quantities supplied by the producers in recent days are insufficient for even one patient.More Related News